Supplementary Appendix
This appendix has been provided by the authors to give readers additional information about their work.
Supplement to: Angel L, Amoroso N, Rafeq S, et al. Tracheostomy in COVID-19 Patients Requiring Mechanical Ventilation.
SUPPLEMENTARY APPENDIX TABLE OF CONTENTS
SUPPLEMENTARY TABLES AND FIGURES
Table 1s. Specialty position statements or communications evaluating the role of tracheostomy in critically ill patients with COVID-19
Page 2
Table 2s. Patient Characteristics, Interventions and Laboratory Results in Patients
with Early Tracheostomy, Late Tracheostomy and No Tracheostomy. Page 3
Table 3s and Figure 1s(a-b). Distribution of Aerosol Mass Concentration Reading for PDT during COVID-19, Trach Collar, and Patient Rooms Pre-Procedure
Page 6
Figure 2s. Balance summary of covariates for patients with Early Tracheostomy and No Tracheostomy before and after matching on propensity scores
Page 7
Figure 3s. Balance summary of covariates for patients with Early Tracheostomy and Late Tracheostomy before and after matching on propensity scores
Page 8
Figure 4s. Balance summary of covariates for patients with Early Tracheostomy and Not Early Tracheostomy (remaining orally intubated with never had a tracheostomy or had a tracheostomy after 13 days) before and after matching on propensity scores
Page 9
Table 1s. Specialty position statements or communications evaluating the role of tracheostomy in critically ill patients with COVID-19
Tracheostomy Guidelines for COVID 19 Patients and Scientific Organization
Reference Number American Association of Otolaryngology-Head and Neck Surgery 11 Canadian Society of Otolaryngology – Head & Neck Surgery 12
Literature review, Univ. California-Los Angeles, USA 13
Ear, Nose and Throat United Kingdom- ENTUK 14
American Association for the Surgery of Trauma 15
A global multidisciplinary Guidance 16
American College of CHEST physicians, American Association of Bronchoscopy and Interventional Pulmonary and the Association of Interventional Pulmonary Program Directors: Expert Panel Report; USA
17
Table 2s. Patient Characteristics, Interventions and Laboratory Results in Patients with Early Percutaneous Dilational (PDT) Tracheostomy, Late PDT and No Tracheostomy.
Variable
Early PDT (N=116)
Late PDT (n=89)
P value*
No Tracheostomy (n=189)
P value*
* Demographics and Medical History
Median age (IQR) – yrs. 59 (46-67) 64 (55-70) 0.01 67 (59-73) <0.001
Female Sex –― n (%) 23 (20%) 26 (29%) 61 (32%) 0.03
Ethnicity/Race – n (%) a
African American 8 (7%) 15 (17%) 0.05 34 (18%) 0.04
Hispanic 31 (27%) 15 (17%) 44 (23%)
White 46 (40%) 41 (46%) 74 (39%
Other 31 (27%) 18 (20%) 37 (20%)
Median Body-mass Index (IQR)b
<30 (n, %) 78 (67%) 61 (69%) 90 (48%)
≥30 (n, %) 38 (33%) 28 (31%) 99 (52%) 0.001
Comorbidities
Hyperlipidemia, Hypertension, Coronary
Disease, Heart Failure 61 (53%) 49 (55%) 93 (49%)
Diabetes 33 (28%) 31 (35%) 58 (31%)
Asthma/Chronic Obstructive Lung Disease 5 (4%) 0 12 (6%)
Chronic Kidney Disease 12 (1%) 11 (12%) 24 (13%)
Cerebrovascular Accident 15 (13%) 13 (15%) 19 (10%)
HIV 4 (3%) 0 3 (2%)
Smoking Status
Active or Previous Smoker 29 (25%) 19 (21%) 54 (29%)
Mechanical Ventilation and Oxygenation Values (median, IQR) Median Plateau Pressure (interquartile range)
– cm of H2O 25 (22, 29) 27 (24, 32) 0.008 27 (22, 32) 0.04
Median Peak Pressure (interquartile range) –
cm of H2O 29 (24, 32) 30 (25, 36) 31 (26, 33)
Median Positive End Expiratory Pressure
(PEEP) (interquartile range)- cm H2O 12 (10,15) 12 (10,15) 12 (10, 15) Positive End Expiratory Pressure (PEEP) (n,
%) 0.02
>12 cm H2O 53 (46%) 32 (36%) 86 (43%)
8-12 cm HO2 54 (47%) 52 (58%) 91 (48%)
<8 cm H2O 0 (8%) 5 (6%) 12 (6%)
Median PaO2/FiO2 ratio (IQR) 123 (81, 188) 90 (67, 154) 0.003 92 (71, 138) 0.001 PaO2/FiO2 ratio (n, %)
200 < PaO2/FIO2 ≤ 300; PEEP > 5 (n, %) 24 (21%) 11 (12%) 25 (13%) 100 < PaO2/FIO2 ≤ 200; PEEP >5 (n, %) 47 (41%) 27 (30%) 61 (32%) PaO2/FIO2 ≤ 100; PEEP > 5 (n, %) 45 (39%) 57 (51%) 103 (54%)
Median PaCO2 41 (35, 50) 37 (32, 53) 38 (32, 47) 0.06
≤ 40 56 (48%) 51 (57%) 107 (57%)
> 40 60 (52%) 38 (43%) 82 (43%)
Chest Radiograph (Start Mechanical Ventilation) Level 0-1: Normal or mild ground glass
infiltrated 2 (2%) 2 (2%) 8 (4%)
Level 2: Multilobar consolidations (2 or more
lobes, not ARDS pattern) 31 (27%) 17 (19%) 43 (23%)
Level 3: Multilobar consolidations with diffuse
distribution 82 (71%) 70 (79%) 137 (73%)
Berlin Definition of ARDS (Start of Mechanical Ventilation) Adult Respiratory Distress Syndrome (ARDS)
criteria by the Berlin Definition (n, %)
Mild (n, %) 12 (10%) 12 (13%) 15 (8%)
Moderate (n, %) 28 (24%) 18 (20%) 37 (20%)
Severe (n, %) 38 (33%) 39 (44%) 80 (43%)
Other 38 (33%) 20 (22%) 57 (30%)
Medications and Interventions Received while on Mechanical Ventilation
Deep sedation and paralysis (n, %) c 66 (57%) 52 (58%) 86 (46%)
High dose of Intravenous Steroids (n, %) d 72 (62%) 53 (60%) 101 (53%)
Hydroxychloroquine (n, %) 110 (95%) 86 (97%) 182 (96%)
Tocilizumab (ACTEMRA) 400 mg Intravenous
Infusion single dose (n, %) 60 (52%) 44 (49%) 71 (38%) 0.02
Prone Positioning (n %) e 72 (62%) 64 (72%) 146 (77%)
Anticoagulation f 85 (73%) 76 (85%) 136 (72%)
Extra corporeal membrane oxygenation
-ECMO (n, %) 36 (31%) 4 (4%) <0.001 5 (3%) <0.001
Dialysis (n, %) 26 (22%) 25 (28%) 68 (36%) 0.02
Baseline Labs and Inflammatory Markers (median value day 1-14 after initiation of mechanical ventilation) White Blood Cell Count (>12 10*3/ul) 57 (49%) 47 (53%) 104 (55%)
Lymphocyte Count (≤5%) 40 (34%) 38 (43%) 97 (51%) 0.006
Ferritin (>1500 ng/ml) 55 (47%) 42 (47%) 72 (39%)
C-Reactive Protein (>100mg/L) 36 (31%) 41 (46%) 0.04 112 (60%) <0.001
Median D dimer (>2500ng/ml) 50 (43%) 42 (47%) 74 (40%)
Percentages may not total 100 because of rounding. IQR denotes interquartile range, HIV human immunodeficiency virus, PaO2 partial pressure of arterial oxygen, FiO2 fraction inspirated oxygen, PaCO2 partial pressure of arterial carbon dioxide, cm of H2O centimeters of water, PTT partial thromboplastin time. P values not shown in the table were non-significant
*P-value for comparison of Early PDT group to Late PDT group using Wilcoxon Rank-sum test for continuous variables and Chi-square test for categorical variables
** P-value for comparison of Early PDT group to No Tracheostomy group using Wilcoxon Rank-sum test for continuous variables and Chi-square test for categorical variables
a Information in race and ethnic group was obtained from entries in medical records as reported by patients
b The body mass index is the weight in kilograms divided by the square of the height in meters.
c Defined as multiple sedatives and a paralytic infusion or paralytic boluses over 2 or more days
d Defined as a dose of IV steroids over 1-2 mg per Kg over 3 or more consecutive days
e Defined as prone positioning > 2 times over 2 or more days
f Full dose anticoagulation with therapeutic anti-Xa level>0.3IU/ml and/or PTT>45 sec
Table 3s and Figure 1s. Distribution of Aerosol Mass Concentration Reading for PDT during COVID-19, Trach Collar, and Patient Rooms Pre-Procedure
Procedure Type (n=total readings) Number of Patients
Exposure
Time (min) Median Total Aerosol Exposure (mg)
Median Aerosol
Concentration Reading (IQR) (mg/m3)
Maximum Aerosol Concentration Reading (mg/m3)
Mean Aerosol Concentration Reading (mg/m3)
COVID-19 Tracheostomy (n=7672) 15 8 0.49 0 (0-0.001) 2.2 0.003
Trach Collar (n=4500) 9 8 1.6 0.001 (0·001-0.004) 150 3.1
Room Pre-Procedure (n=2067) 15 4 0.35 0 (0-0.002) 0.71 0.003
We found that the median total aerosol exposure concentration readings (Figure 3S-a) and the distribution of aerosol reading for the new PDT procedure were significantly lower compared to the trach collar (p<·0001) and similar to the pre-procedure room readings. For the comparison of aerosol concentration readings between procedure types, the nonparametric Mood median test was used (α<0·05). Analyses were
performed using SAS, version 9·4 (SAS Institute, Cary NC).
Figure 1s-a. Figure 1s-b
Figure 2s. Balance summary of covariates for patients with Early Tracheostomy and No
Tracheostomy before and after matching on propensity scores with caliper 0.5. Standardized mean differences in the unmatched and matched sample (297 patients). All the p values in all the
variables used in the propensity score matched samples are non-significant.
Figure 3s. Balance summary of covariates for patients with Early Tracheostomy and Late Tracheostomy before and after matching on propensity scores. Standardized mean differences in the unmatched and matched sample (205 patients). All the p values in all the variables used in the propensity score matched samples are non-significant
Figure 4s. Balance summary of covariates for patients with Early Tracheostomy and Not Early Tracheostomy (Patients remained intubated that did not have a tracheostomy or later (>13 days) have a tracheostomy) before and after matching on propensity scores with caliper 0.5. Standardized mean differences in the unmatched and matched sample (386 patients). All the p values in all the variables used in the propensity score matched samples are non-significant